Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Orbis expects a long-term reversal in US equity outperformance and is positioning the fund in deeply undervalued, idiosyncratic global opportunities like biotech (Genmab, Icon) and entertainment (IMAX).
Full Quick Take
Orbis expects a long-term reversal in US equity outperformance and is positioning the fund in deeply undervalued, idiosyncratic global opportunities like biotech (Genmab, Icon) and entertainment (IMAX).
